Hepatitis C: Grading and Staging by MR

This study has been completed.

First Received: April 24, 2003 Last Updated: November 29, 2007 History of Changes

Sponsor:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:	NCT00059397

Purpose

To compare MR imaging findings with biopsy for grading and staging early hepatitis C.

Condition
Hepatitis

Study Type:	Observational
Study Design:	Prospective
Official Title:	Hepatitis C: Grading and Staging by MR

Resource links provided by NLM:

MedlinePlus related topics: Hepatitis Hepatitis C

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Estimated Enrollment:	80
Study Start Date:	April 2003

Eligibility

Criteria

Referral only

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00059397

Locations

United States, Pennsylvania
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107

Sponsors and Collaborators

More Information

No publications provided

Study ID Numbers:	HCGSMR (DK62765)
Study First Received:	April 24, 2003
Last Updated:	November 29, 2007
ClinicalTrials.gov Identifier:	NCT00059397 History of Changes
Health Authority:	United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Hepatitis C

Additional relevant MeSH terms:

Virus Diseases
Hepatitis
RNA Virus Infections
Liver Diseases

Digestive System Diseases
Flaviviridae Infections
Hepatitis, Viral, Human
Hepatitis C

ClinicalTrials.gov processed this record on November 25, 2009